Enroll Now or Learn More
OVERVIEW
LEARN MORE
MODULES
Module A - Creating Value
Module B - Managing Value
Module C - Growing Value
DATES
Module A: October 7-8, 2009 (2 days)
Module B: November 2-3, 2009 (2 days)
Module C: December 8-9, 2009 (2 days)
Additional dates:
Module A: October 7-8, 2010
Module B: November 4-5, 2010
Module C: December 7-8, 2010
FEES
Individuals: $1950 USD per module
Full Program (all 3 modules): $5500 USD (savings of $350 USD)
Corporate offer: 3 Full Program registrations for $15,000 USD
Scholarship Application
SPEAKERS
NETWORKING RECEPTION
SPONSORS
PAST ATTENDEES
LOGISTICS
BROCHURE
PODCAST
RELATED VIDEO
TESTIMONIALS
Note: All speakers and fees are subject to change.

 

BioExec Institute
Module A - Creating Value

Day 1: BioProduct Development & Management

"Understanding the challenges and avoiding the pitfalls is key to successfully bringing bioproducts from research through development."

Biopharmaceuticals, medical devices, and other biological products face a plethora of regulatory and safety issues in addition to the major challenges all products face in moving from concept to reality. Understanding the requirements for and the inter-relation between manufacturing, clinical trials, regulatory approvals, and safety testing is essential to success. Industry leaders will join session participants to discuss the trade-offs caused by exploring new R&D models with the goal of creating value for your organizations.

Featured topics:

Day 2: Manufacturing & Operations

"Biologics and biopharmaceuticals manufacturing is a linchpin between product development and commercialization."

New product development demands technology-specific manufacturing assets and upfront capital investment. Evaluation of innovative designs for manufacturing necessitates an ongoing assessment and alignment with commercial strategy. While manufacturing activities and organizations may be viewed as singular and insular, executives must have an integrated knowledge of the biologics industry environment, pre-clinical through clinical development, economics and science, and stakeholder requirements. Continuous evaluation of product life cycle management, technology, manufacturing options, and infrastructure are critical to optimizing production flexibility and asset utilization. Further, a dynamic regulatory and compliance/quality environment mandates ongoing assessment and implementation of new requirements and systems to minimize business risks.

Featured topics: